Study shows endemic cholera can be controlled with oral vaccinesNovember 27, 2007SEATTLE -- Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle. Longini and colleagues will report their findings online Nov. 27 in PLoS Medicine. While oral cholera vaccines have been available to protect travelers for more than a decade, they have not been used for widespread control of the disease in cholera-prone (endemic) regions in part because their protective potential has been underestimated. In fact, using a computer simulation model based on data from a large-scale cholera-vaccine trial involving 200,000 people in Matlab, Bangladesh, Longini and colleagues suggest that internationally licensed, killed whole-cell cholera vaccines (OCVs) may be highly effective in controlling cholera when given via mass immunization. Longini and colleagues estimate that cholera cases could be reduced nearly 90 percent among the unvaccinated if just 50 percent of the population received an oral vaccination biannually. Vaccinating just 30 percent of the population every two years would achieve an overall cholera reduction rate of 76 percent. In populations with less experience with cholera than Matlab, at least 70 percent of the population would need to be vaccinated to control the disease. "This is the first scientific work that shows how we could control cholera on a global level," said Longini, also a professor of biostatistics at the University of Washington School of Public Health and Community Medicine. "Once you get up to about 50 percent of the population vaccinated, you can drive the epidemic into practically nothing." Endemic cholera is a bacterial infection of the small intestine that causes acute, watery diarrhea. If untreated, it can lead to potentially fatal dehydration. Although advances in rehydration therapy have made cholera a treatable disease in areas with sufficient medical care, it remains a fatal condition among the world's most impoverished populations. The disease is caused by ingesting food or water contaminated with a comma-shaped bacterium called Vibrio cholerae. Co-authors on the paper included researchers from Emory University in Atlanta; the International Vaccine Institute in Seoul, Korea; and the International Centre for Diarrhoeal Disease Research in Bangladesh. "These important findings stem from the recent recognition that oral vaccines against cholera confer herd protection - protection of nonvaccinated neighbors of vaccinated persons," said John Clemens, M.D., director-general of the International Vaccine Institute and paper co-author. "I believe this study will have an impact on the public-health community's approach to controlling cholera," he said. Fred Hutchinson Cancer Research Center |
|||||||||||||||||||||
| Related Cholera Current Events and Cholera News Articles New insight into predicting cholera epidemics in the Bengal Delta Cholera, an acute diarrheal disease caused by the bacterium Vibrio cholerae, has reemerged as a global killer. Outbreaks typically occur once a year in Africa and Latin America. But in Bangladesh the epidemics occur twice a year - in the spring and again in the fall. Designing probiotics that ambush gut pathogens Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Vi typhoid vaccine proves highly effective in young children A new study has found that a currently available yet underused vaccine against typhoid fever is highly effective in young children and protects unvaccinated neighbors of vaccinees. Simple measures may prevent transmission of stomach ulcer bacteria The stomach ulcer bacterium Helicobacter pylori is not transmitted through drinking water as previously thought, but rather through vomit and possibly faeces. Superbug risk to war wounded Soldiers who survive severe injuries on battlefields such as those in Iraq and Afghanistan can be at risk from developing infections of their wounds with multidrug resistant bacteria. Flies May Spread Drug-Resistant Bacteria from Poultry Operations Researchers at the Johns Hopkins Bloomberg School of Public Health found evidence that houseflies collected near broiler poultry operations may contribute to the dispersion of drug-resistant bacteria and thus increase the potential for human exposure to drug-resistant bacteria. Bacterial pathogens and rising temperatures threaten coral health Coral reefs around the world are in serious trouble from pollution, over-fishing, climate change and more. The last thing they need is an infection. But that's exactly what yellow band disease (YBD) is-a bacterial infection that sickens coral colonies. Of Mice and Peanuts: A new mouse model for peanut allergy Chicago researchers report the development of a new mouse model for food allergy that mimics symptoms generated during a human allergic reaction to peanuts. From poison to prevention One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don't cause illness. Trickier still is to ensure that such weapons against infectious disease can be safely disarmed, once their immunogenic work is done. Blocking the spread of antibiotic resistance in bacteria It's as simple as A, T, G, C. Northwestern University scientists have exploited the Watson-Crick base pairing of DNA to provide a defensive tool that could be used to fight the spread of antibiotic resistance in bacteria -- one of the world's most pressing public health problems. More Cholera Current Events and Cholera News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||